Current Standards of Care & Advances in Immunotherapy

A Roundtable Discussion:

Panelists

A panel of experts in the practice of and research surrounding immunotherapy gathered in Phoenix in November 2010 during the Annual Meeting of the American College of Allergy, Asthma and Immunotherapy (ACAAI/the College) to share their perspectives on the latest standards and recent advances in immunotherapy.  

The panel discussion was co-chaired by:

Linda S. Cox, MD, associate clinical professor of medicine, Nova Southeastern University, Fort Lauderdale, Fla., and immediate past chair, ACAAI Immunotherapy and Diagnostics Committee

Dana V. Wallace, MD, associate clinical professor of medicine, Nova Southeastern University, Fort Lauderdale, Fla., and president, ACAAI

Other participants included:

David I. Bernstein, MD, professor of internal medicine and co-director of the allergy training program, University of Cincinnati College of Medicine and member, ACAAI Board of Regents

Michael S. Blaiss, MD, clinical professor of pediatrics and medicine, University of Tennessee Health Science Center, Memphis, Tenn.

Ira Finegold, MD, chief of allergy and director of the Cook Institute of Allergy, St. Luke’s Roosevelt Hospital and clinical professor of medicine, Columbia University, New York City and chairman, ACAAI Immunotherapy and Diagnostics Committee 

Bobby Q.  Lanier, MD, clinical professor of immunology, University of North Texas Health Science Center, Fort Worth, Texas, and executive medical director, ACAAI

Harold S. Nelson, MD, professor of medicine, National Jewish Health and the University of Colorado School of Medicine, Denver

All of the panelists also are allergists in private practice.

Topics:

• Subcutaneous immunotherapy (SCIT)
• Sublingual immunotherapy (SLIT)
• Other immunotherapy delivery methods (intranasal, epicutaneous and intralymphatic)
• The current and future role of the allergist in immunotherapy